Nordic Nanovector Presentations at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2019 Annual Meeting

On June 11, 2019 Nordic Nanovector ASA (OSE: NANO) reported that the company and its collaborators will present data and analyses from its preclinical studies with Betalutin (177Lu-lilotomab satetraxetan) and with 212Pb-NNV003, a next-generation targeted alpha therapy comprising Nordic Nanovector’s chimeric anti-CD37 antibody (NNV003) coupled with the alpha-particle-generator lead-212 (212Pb), at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2019 Annual Meeting, to be held in Anaheim, CA, USA on 22-24 June (Press release, Nordic Nanovector, JUN 11, 2019, View Source [SID1234553447]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the presentations are:

Combination of 177Lu-lilotomab satetraxetan with rituximab synergistically improves in-vivo therapeutic efficacy in a rituximab-resistant non-Hodgkin lymphoma (NHL) model

Authors: M.M. Malenge, A.H. Ree, T. Stokke, J. Dahle and A.H.V. Repetto-Llamazares
Abstract: 351 (click to access abstract online)
Session: 42. Oncology, Basic and Translational (Basic Science) III
Date/time: 24 June, 17:25-17:35 Pacific daylight time (PDT)

Targeted alpha therapy with 212Pb-NNV003 for the treatment of CD37 positive B-cell chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL)

Authors: A. Saidi, A.F. Maaland, J. Torgue, H. Heyerdahl and J. Dahle
Abstract: 354 (click to access abstract online)
Session: 42. Oncology, Basic and Translational (Basic Science) III
Date/time: 24 June, 17:55-18:05 PDT
The posters will be added to www.nordicnanovector.com in the section What We Do/Scientific Publications/Scientific Posters on 24 June to coincide with the sessions in which they are presented.